VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
TECHBio-Techne Corporation
$57.94$9.1B
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksTECHEarnings History

TECH logoBio-Techne Corporation (TECH) Earnings History

Earnings Pressure

36 years of earnings data (1990–2025) · 5-year EPS trend is negative

TTM Net Income
$110M
● Profitable
TTM EPS (Diluted)
$0.70
Per share, diluted
YoY EPS Growth
-56.2%
Declining
Net Margin
6.0%
After-tax profitability
EPS Growth Rate (CAGR)
1Y-56.2%
3Y-34.8%
5Y-20.5%
10Y-4.4%
Operating Margin8.4%
Gross Margin64.8%
Return on Equity3.7%
Return on Assets2.8%
Record Annual Net Income$285MFY2023
Record Quarterly EPS$0.76Q2 2020
Consecutive Profitable Years36years
Q3 2026
Net Income$51M
EPS (Diluted)$0.32
YoY Growth-56.2%Declining
QoQ Growth+34.3%Excellent

Loading earnings history...

Bio-Techne Corporation (TECH) Earnings Overview

As of June 22, 2026, Bio-Techne Corporation (TECH) reported trailing twelve-month net income of $110M, reflecting -56.2% year-over-year growth. The company earned $0.70 per diluted share over the past four quarters, with a net profit margin of 6.0%.

Looking at the long-term picture, TECH's 5-year EPS compound annual growth rate (CAGR) stands at -20.5%, signaling declining earnings. The company achieved its highest annual net income of $285M in fiscal 2023.

Bio-Techne Corporation maintains positive profitability with a gross margin of 64.8%, operating margin of 8.4%, and net margin of 6.0%. The company continues to generate positive earnings from operations. View revenue history →

Compared to peers including RGEN ($51M net income, 6.6% margin), NEOG (-$603M net income, -122.1% margin), AZTA (-$178M net income, -9.4% margin), TECH has room to improve margins relative to the peer group. Compare TECH vs RGEN →

TECH Earnings vs Peers

Earnings metrics vs comparable public companies

CompanyTTM Net IncomeTTM EPSNet MarginROEYoY GrowthCompare
TECH logoTECHCurrent
$110M$0.706.0%3.7%-56.2%—
RGEN logoRGEN
$51M$0.916.6%2.4%+287.0%
NEOG logoNEOG
-$603M$-2.77-122.1%-41.9%-11463.2%
AZTA logoAZTA
-$178M$-3.87-9.4%-3.2%+60.5%
RVTY logoRVTY
$241M$2.158.5%3.2%-13.7%
MESO logoMESO
-$102M$-0.80-593.9%-19.0%+5.6%
Best in group
Lowest in group

TECH Historical Earnings Data (1990–2025)

36 years
Fiscal Year Net Income YoY % Operating Income EPS (Diluted) Net Margin Op. Margin
2025$73M-56.3%$102M$0.466.0%8.4%
2024$168M-41.1%$207M$1.0514.5%17.8%
2023$285M+4.9%$299M$1.7625.1%26.3%
2022$272M+93.8%$297M$1.6624.6%26.8%
2021$140M-38.8%$237M$0.8715.1%25.5%
2020$229M+138.7%$157M$1.4531.0%21.3%
2019$96M-23.4%$126M$0.6213.5%17.6%
2018$125M+62.2%$136M$0.8219.5%21.2%
2017$77M-26.0%$122M$0.5213.7%21.6%
2016$104M-3.0%$151M$0.7020.9%30.2%
2015$108M-2.9%$147M$0.7223.8%32.5%
2014$111M-1.4%$160M$0.7531.0%44.7%
2013$113M+0.2%$158M$0.7636.2%51.0%
2012$112M+0.0%$166M$0.7635.7%52.8%
2011$112M+2.3%$163M$0.7638.7%56.2%
2010$110M+4.3%$156M$0.7340.8%58.1%
2009$105M+1.6%$151M$0.6939.9%57.1%
2008$104M+21.7%$144M$0.6640.2%56.1%
2007$85M+16.0%$124M$0.5438.1%55.6%
2006$73M+10.9%$109M$0.4636.2%53.6%
2005$66M+24.9%$98M$0.4037.0%54.7%
2004$53M+16.6%$82M$0.3232.8%51.0%
2003$45M+67.3%$68M$0.2731.3%46.7%
2002$27M-20.3%$53M$0.1620.7%40.4%
2001$34M+28.1%$46M$0.2029.5%39.7%
2000$27M+59.2%$39M$0.1625.6%37.9%
1999$17M+9.9%$25M$0.1018.4%27.6%
1998$15M+39.4%$21M$0.1022.6%31.5%
1997$11M+26.7%$15M$0.0717.9%25.1%
1996$9M+28.4%$12M$0.0615.8%22.3%
1995$7M+31.4%$9M$0.0414.0%19.7%
1994$5M+15.9%$8M$0.0412.7%18.9%
1993$4M+120.0%$7M$0.0315.3%24.0%
1992$2M+25.0%$4M$0.019.0%18.4%
1991$2M+60.0%$2M$0.018.3%11.4%
1990$1M-$2M$0.016.4%9.6%

Download Data

Export TECH earnings history in CSV or JSON format

Free sign-in required to download data

Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

36+ years return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

TECH — Frequently Asked Questions

Quick answers to the most common questions about buying TECH stock.

What is TECH earnings per share (EPS)?

TECH trailing twelve-month (TTM) diluted EPS is $0.70, reflecting -56.2% year-over-year growth. The 5-year EPS CAGR is -20.5%. Complete EPS history from 1990 to 2025 is available in the table on this page.

What is Bio-Techne Corporation's net income?

Bio-Techne Corporation (TECH) trailing twelve-month net income is $110M as of 2025. Earnings declined -56.2% year-over-year. Bio-Techne Corporation has been profitable for 36 consecutive years.

Is TECH profitable?

Yes, TECH is profitable with a TTM net income of $110M and a net profit margin of +6.0%. Bio-Techne Corporation has generated profits for 36 consecutive years.

What is TECH's earnings growth rate?

TECH compound annual EPS growth rates (CAGR): 1-Year: -56.2%, 3-Year: -34.8%, 5-Year: -20.5%, 10-Year: -4.4%. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 1990 to 2025.

What are TECH's profit margins?

Bio-Techne Corporation net profit margin is +6.0%, operating margin is +8.4%, and gross margin is +64.8%. Margins are within a typical range for the sector. Return on Equity is +3.7%.

Is TECH growing earnings?

TECH earnings are declining — EPS fell -56.2% year-over-year. TTM net income dropped to $110M. This contrasts with the 5-year CAGR of -20.5%.

What was TECH's best earnings year?

Bio-Techne Corporation's highest annual net income on record is $285M, achieved in fiscal year 2023. Earnings history on this page spans 1990 to 2025 and includes all annual and quarterly figures.

What were TECH's earnings last quarter?

TECH's most recent reported quarter was Q3 2026. Net income was $51M with diluted EPS of $0.32. For a full breakdown of all quarters, see the quarterly earnings table on this page.

TECH Earnings Over Time (1990–2025)

Net income & EPS — annual and quarterly view